Eric Lefkofsky: AI-driven Preview platform delivers pathology insights to doctors within 24 hours

Eric Lefkofsky: AI-driven Preview platform delivers pathology insights to doctors within 24 hours
Preview AI speeds doctor insights

The adoption of artificial intelligence is accelerating in the medical diagnostics sector. Eric Lefkofsky announced the Preview platform, which uses proprietary AI models trained on millions of pathology slides to provide doctors with critical insights within 24 hours of sample receipt. According to Lefkofsky, this product is set to transform patient care by making timely analysis more accessible to clinicians. The technology has the potential to reshape the diagnostic workflow, enabling faster and possibly more accurate treatment decisions.

Lefkofsky’s latest announcement follows recent regulatory milestones for his healthcare ventures. Earlier this year, Tempus secured U.S. FDA approval for its tumor-only xT CDx genomic profiling test. The green light expanded advanced diagnostics options for more patients.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.